Impact of Energy Drinks and Panax Ginseng on Heart Rhythm
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
To assess the cardiac effects of an energy drink and Panax Ginseng in healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 6, 2015
CompletedFirst Posted
Study publicly available on registry
October 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedOctober 8, 2015
October 1, 2015
9 months
October 6, 2015
October 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
QTc interval changes
5.5 hours over 3 visits
Systolic blood pressure changes
5.5 hours over 3 visits
Secondary Outcomes (5)
QT interval changes
5.5 hours over 3 visits
PR interval changes
5.5 hours over 3 visits
QRS duration changes
5.5 hours over 3 visits
Heart rate changes
5.5 hours over 3 visits
Diastolic blood pressure changes
5.5 hours over 3 visits
Study Arms (3)
Energy Drink
EXPERIMENTALTwo 16 ounce containers of an Energy Drink
Panax Ginseng
ACTIVE COMPARATOR800 mg of Panax Ginseng in 70 mL of cherry syrup, 20 mL of lime juice, 410 mL of carbonated water
Placebo
PLACEBO COMPARATOR70 mL of cherry syrup, 20 mL of lime juice, 410 mL of carbonated water
Interventions
Eligibility Criteria
You may qualify if:
- Healthy male or female adults 18-40 years old.
You may not qualify if:
- Baseline corrected QT (QTc) interval greater than 440 milliseconds,
- blood pressure at initial screening appointment greater than 140/90 mmHg,
- concurrent use of prescriptions or OTC medications taken on a daily basis,
- pregnant females,
- patients with any baseline ECG abnormalities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2015
First Posted
October 8, 2015
Study Start
June 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
October 8, 2015
Record last verified: 2015-10